Drugs / Cardioplexol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03823521 Background | Nov 2018 → Oct 2021 | cardiac valvular defect, coronary artery intramyocardial course | Swiss Cardio Technologies AG | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cardioplexol | “Cardioplexol™ will be adminstered in cardiac surgery as cardioplegic solution” NCT03823521 ↗ |